Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study
Antibodies · 10.07.2026 · 15 (4) · 58
DOI: 10.3390/antib15040058 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Antibodies, online erschienen am 10.07.2026. Verfasst von Hanna Cholerzyńska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, Poznan University of Medical Sciences, 60-812 Poznań, Poland. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Antinuclear antibodies (ANA) can be detected in patients with rheumatoid arthritis (RA) and pose many diagnostic challenges, especially when RA presents an atypical course and requires differentiation from other systemic connective tissue diseases (sCTDs). This study assessed ANA fluorescence patterns and immunoblot profiles, as well as the relationships between ANA titers, antibody expression intensity, and markers of disease activity in patients with RA.
Methods
This single-center, cross-sectional, observational study included 81 RA patients (53 ANA-positive) meeting the 2010 ACR/EULAR classification criteria. ANA titers and fluorescence patterns were assessed using indirect immunofluorescence. Anti-extractable nuclear antigen (ENA) autoantibody profiles and expression intensity were assessed using immunoblot analysis. Demographic, clinical, and laboratory data were obtained. Spearman’s rank correlation coefficient was used to analyze the relationship between ANA titers and selected variables. Univariate and multivariate logistic regression analyses were performed to identify factors associated with ANA positivity.
Results
The cohort consisted primarily of women (86.4%) with moderate disease activity. ANA fluorescence patterns were heterogeneous, with nucleolar and homogeneous patterns most frequently observed. Immunoblot analysis also revealed diverse autoantibody profiles without a clearly dominant specificity. Ro-52, SS-A, and Sm antibodies were detected more frequently, although their prevalence remained relatively low. No statistically significant correlations were found between ANA titers and inflammatory markers, serological parameters, or disease activity indices.
Conclusions
RA patients with positive ANA demonstrated marked immunological heterogeneity, without concomitant symptoms of sCTD. A positive result in RA may reflect generalized immune dysregulation rather than a distinct clinical subtype. Further studies with larger cohorts are needed to clarify the clinical significance of ANAs in rheumatoid arthritis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, Poznan University of Medical Sciences, 60-812 Poznań, Poland.
- Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Department of Rheumatology, Rheumatological Centre, 63-100 Śrem, Poland.
- Department of Rheumatology, Rehabilitation and Internal Diseases, Poznan University of Medical Sciences, 61-545 Poznań, Poland.
ORCID-Profile: Hanna Cholerzyńska, Gabriela Kot, Łukasz Świątek, Bogna Grygiel-Górniak
Zitieren
APA
Cholerzyńska, H., Kot, G., Świątek, Ł., & Grygiel-Górniak, B. (2026). Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study. Antibodies, 15(4), 58. https://doi.org/10.3390/antib15040058
Vancouver
Cholerzyńska H, Kot G, Świątek Ł, Grygiel-Górniak B. Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study. Antibodies. 2026;15(4):58. doi:10.3390/antib15040058
BibTeX
@article{Cholerzyska2026,
author = {Cholerzyńska, Hanna and Kot, Gabriela and Świątek, Łukasz and Grygiel-Górniak, Bogna},
title = {Beyond the Surface: Antinuclear Antibodies in Rheumatoid Arthritis—Experiences from a Single-Center, Cross-Sectional Observational Study},
journal = {Antibodies},
year = {2026},
volume = {15},
number = {4},
pages = {58},
doi = {10.3390/antib15040058}
}
EUVIMED